Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $40.2 million.

  • Dna X's Liabilities and Shareholders Equity fell 1816.59% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.0 million, marking a year-over-year decrease of 2142.82%. This contributed to the annual value of $39.7 million for FY2024, which is 2909.19% down from last year.
  • According to the latest figures from Q3 2025, Dna X's Liabilities and Shareholders Equity is $40.2 million, which was down 1816.59% from $36.1 million recorded in Q2 2025.
  • Dna X's 5-year Liabilities and Shareholders Equity high stood at $58.6 million for Q3 2023, and its period low was $36.0 million during Q1 2025.
  • Over the past 5 years, Dna X's median Liabilities and Shareholders Equity value was $41.1 million (recorded in 2021), while the average stood at $44.6 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 4279.66% in 2021, then surged by 4410.98% in 2023.
  • Dna X's Liabilities and Shareholders Equity (Quarter) stood at $41.1 million in 2021, then skyrocketed by 30.65% to $53.7 million in 2022, then rose by 4.39% to $56.0 million in 2023, then decreased by 29.09% to $39.7 million in 2024, then grew by 1.21% to $40.2 million in 2025.
  • Its Liabilities and Shareholders Equity was $40.2 million in Q3 2025, compared to $36.1 million in Q2 2025 and $36.0 million in Q1 2025.